Hemostats Market Report, Upcoming Trends, Demand, Regional Analysis and Forecast 2025

13/gen/2021 06:34:31 IMARC Group Contatta l'autore

Hemostats are the medical devices that compress blood vessels and reduce the flow of blood or other fluids. They are majorly used during surgical procedures to control bleeding in patients. Hemostatic agents enable faster wound healing, reduce operative time, enhance patient's recovery, and help in treating anticoagulated patients. Various surgical hemostatic agents are available based on different compositions, immunogenicity, and the mechanism of action, application and adherence.

According to IMARC Group's latest report, titled “Hemostats Market Report: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,” the global hemostats market to continue its moderate growth during the next five years.

Market Trends

The growing prevalence of chronic blood-related disorders, cesarean deliveries, fatal injuries, organ surgeries, etc., is primarily driving the demand for hemostats to reduce blood loss. Moreover, several technological advancements have led to the development of absorbable adjunctive hemostats that help in controlling disruptive bleeding more efficiently than the conventional devices. Additionally, the growing utilization of nano- and micro-materials for treating uncontrolled hemorrhage and internal bleeding is also augmenting the market growth. Several manufacturers have introduced advanced laparoscopic hemostats to enhance surgical operations quality and facilitate less invasive procedures, which are further expected to drive the global market.

Request for a free sample copy of this report: 
https://www.imarcgroup.com/hemostats-market/requestsample

Some of these key players include:

  1. Arch Therapeutics Inc.
  2. Baxter International Inc.
  3. Braun Melsungen Aktiengesell
  4. R. Bard Inc.
  5. GELITA MEDICAL GmbH
  6. Integrates LifeSciences Corporation
  7. Johnson & Johnson
  8. Pfizer Inc.
  9. Stryker Corporation
  10. Teleflex Incorporated
  11. Z-Medica LLC.

Breakup by Product:

  1. Thrombin Based
  2. Combination Based
  3. Oxidized Regenerated Cellulose Based
  4. Gelatin Based
  5. Collagen Based

Breakup by Application:

  1. Orthopedic Surgery
  2. General Surgery
  3. Neurological Surgery
  4. Cardiovascular Surgery
  5. Reconstructive Surgery
  6. Gynecological Surgery
  7. Others

Breakup by Formulation:

  1. Matrix and Gel Hemostats
  2. Sheet and Pad Hemostats
  3. Sponge Hemostats
  4. Powder Hemostats

Explore full report with table of contents: https://www.imarcgroup.com/hemostats-market

Breakup by Region:

  1. North America
  2. Asia Pacific
  3. Europe
  4. Latin America
  5. Middle East and Africa

Browse Related Report:

https://www.imarcgroup.com/vital-signs-monitoring-devices-market

https://www.imarcgroup.com/capnography-devices-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: + 1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl